Whilst WIZR clearly have a way to go, and they also clearly need to start scaling to once again increase revenues & increase the loan book size, it is good to see the continued positive trends:
Unrestricted cash now up to $28.4m (up from $21.7m at 31 March 2024)
7% increase in loan originations to $55.2 for the quarter - with a quarter "exit run rate" of a 30% increase in loan originations ($67.5m)
Continually increasing nett interest margins
Continually increasing yields - especially the "front book yields"
Nett Operating Cash Inflows of $4.0m for the quarter
Now that they have $28.4m in unrestricted cash & they also the debt facility sorted, will be interesting to see how they start to increase the loan originations amounts & loan book going forward
Also, it shouldn't be too long before interest rates start to decrease - which will obviously help this business significantly
All in all, this report was a step in the right direction IMO
- Forums
- ASX - By Stock
- Ann: WZR Q4FY24 Market Update.
WZR
wisr limited
Add to My Watchlist
0.00%
!
2.5¢

Whilst WIZR clearly have a way to go, and they also clearly need...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.87M |
Open | High | Low | Value | Volume |
2.5¢ | 2.6¢ | 2.5¢ | $5.034K | 199.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 2006482 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 85000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 2006482 | 0.025 |
5 | 2510000 | 0.024 |
2 | 140000 | 0.023 |
2 | 230000 | 0.022 |
1 | 40000 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 85000 | 1 |
0.027 | 699463 | 6 |
0.028 | 502402 | 7 |
0.029 | 735819 | 5 |
0.030 | 1000773 | 7 |
Last trade - 15.17pm 04/07/2025 (20 minute delay) ? |
Featured News
WZR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online